Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00331058 · ClinicalTrials.gov registry record · Phase 1
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
A Phase 1 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00331058 is a Phase 1 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 58 participants.
The verdict
NCT00331058, a Phase 1 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
The primary goal of this study is to compare the expression of key GSK drug targets across the 4 asthma phenotypes and healthy subjects and secondarily to evaluate changes in target expression in response to a 2-week course of corticosteroids across the 4 asthma phenotypes. Each asthmatic subject in this study will undergo two bronchoscopies. Each healthy subject will undergo one bronchoscopy.
Interventions
- PROCEDURE Bronchoscopsy
- PROCEDURE Prednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2006-02-18 |
| Est. Completion | 2011-07-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00331058
The ClinicalTrials.gov registry entry for NCT00331058 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bronchoscopsy is the first listed.
NCT00331058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00331058 about?
NCT00331058 is a clinical study titled "Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects". The primary goal of this study is to compare the expression of key GSK drug targets across the 4 asthma phenotypes and healthy subjects and secondarily to evaluate changes in target expression in response to a 2-week course of corticosteroids across the 4 asthma phenotypes. Each asthmatic subject in...
What is the current status of trial NCT00331058?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2006-02-18. Estimated completion is 2011-07-07.
What interventions are being tested in trial NCT00331058?
The interventions under investigation include: Bronchoscopsy (PROCEDURE), Prednisolone (PROCEDURE).
Who is sponsoring clinical trial NCT00331058?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.